Skip to content
MedsAcross

Medicine

Chromium 40 mcg/10 mL injection

Chromic · Intravenous · Hospira
Available on requestPrescription onlyUS FDA

Chromium 40 mcg/10 mL injection is a prescription medicine containing Chromic for intravenous use, marketed by Hospira, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20 to 25ºC (68 to 77ºF).

Key facts

Active ingredient (INN)
Chromic
Brand
Chromium
Strength
40 mcg/10 mL
Dosage form
Injection
Route
Intravenous
Packs
25 vials of 10 mL
Marketing authorisation holder
Hospira
Manufacturer
Hospira
Origin register
US FDA, United States
Storage
Store at 20 to 25ºC (68 to 77ºF).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
30 June 2005
Identifiers
RxCUI 204401DailyMed set ID b4d01ebb-a36e-44b7-028c-43c0ab2d13b4, da207ca8-7836-4c66-92fe-36cc89baf773NDC 0409-4093Application NDA018961

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
25 vial, single-dose in 1 tray / 10 mL in 1 vial, single-dose0409-4093-01Hospira30 June 2005
25 vial, single-dose in 1 tray / 10 mL in 1 vial, single-dose0409-4093-10Hospira27 April 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 26 June 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Chromic 40 mcg/10 mL injection.

Compare 1

Clinical summary

Chromic is a prescription medicine indicated as a supplement to intravenous solutions given for TPN. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. MedsAcross supplies Chromic for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Chromic

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Chromium 40 mcg/10 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.